249 related articles for article (PubMed ID: 28940538)
1. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.
Wang Z; Hu L; Salari K; Bechis SK; Ge R; Wu S; Rassoulian C; Pham J; Wu CL; Tabatabaei S; Strand DW; Olumi AF
J Pathol; 2017 Dec; 243(4):457-467. PubMed ID: 28940538
[TBL] [Abstract][Full Text] [Related]
2. Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland.
Xue B; Wu S; Sharkey C; Tabatabaei S; Wu CL; Tao Z; Cheng Z; Strand D; Olumi AF; Wang Z
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):465-474. PubMed ID: 32029929
[TBL] [Abstract][Full Text] [Related]
3. Enhanced prostatic Esr1
Sharkey C; Long X; Al-Faouri R; Strand D; Olumi AF; Wang Z
J Pathol; 2024 Jul; 263(3):300-314. PubMed ID: 38606616
[TBL] [Abstract][Full Text] [Related]
4. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate.
Ge R; Wang Z; Bechis SK; Otsetov AG; Hua S; Wu S; Wu CL; Tabatabaei S; Olumi AF
Am J Pathol; 2015 Mar; 185(3):870-82. PubMed ID: 25700986
[TBL] [Abstract][Full Text] [Related]
5. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
6. Extracts of
Song KH; Seo CS; Yang WK; Gu HO; Kim KJ; Kim SH
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803357
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol A exposure during adulthood alters expression of aromatase and 5α-reductase isozymes in rat prostate.
Castro B; Sánchez P; Torres JM; Preda O; del Moral RG; Ortega E
PLoS One; 2013; 8(2):e55905. PubMed ID: 23405234
[TBL] [Abstract][Full Text] [Related]
9. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
10. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
11. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
Austin DC; Strand DW; Love HL; Franco OE; Grabowska MM; Miller NL; Hameed O; Clark PE; Matusik RJ; Jin RJ; Hayward SW
Prostate; 2016 Aug; 76(11):1004-18. PubMed ID: 27197599
[TBL] [Abstract][Full Text] [Related]
12. 5alpha-reductase activity in the prostate.
Steers WD
Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
[TBL] [Abstract][Full Text] [Related]
13. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
[TBL] [Abstract][Full Text] [Related]
14. Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia.
Kang PM; Kim YJ; Seo WT; Kang SH; Kim TS; Chun BK; Seo WI; Jeong JY; Chung JI
World J Urol; 2019 Apr; 37(4):709-718. PubMed ID: 30069579
[TBL] [Abstract][Full Text] [Related]
15. 5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.
Godoy A; Kawinski E; Li Y; Oka D; Alexiev B; Azzouni F; Titus MA; Mohler JL
Prostate; 2011 Jul; 71(10):1033-46. PubMed ID: 21557268
[TBL] [Abstract][Full Text] [Related]
16. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.
Bechis SK; Otsetov AG; Ge R; Wang Z; Vangel MG; Wu CL; Tabatabaei S; Olumi AF
J Urol; 2015 Oct; 194(4):1031-7. PubMed ID: 25916673
[TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
18. Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.
Wang Z; Deng T; Long X; Lin X; Wu S; Wang H; Ge R; Zhang Z; Wu CL; Taplin ME; Olumi AF
PLoS One; 2020; 15(3):e0229754. PubMed ID: 32134978
[TBL] [Abstract][Full Text] [Related]
19. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
20. 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate.
Délos S; Carsol JL; Fina F; Raynaud JP; Martin PM
Int J Cancer; 1998 Mar; 75(6):840-6. PubMed ID: 9506528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
